Jim Simons Aeglea Bio Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.11 - $0.46 $23,309 - $97,474	211,900 Added 117.01%	393,000 $177,000
Q1 2023 May 12, 2023	BUY	$0.29 - $0.61 $8,700 - $18,300	30,000 Added 19.85%	181,100 $53,000
Q4 2022 Feb 13, 2023	SELL	$0.35 - $1.54 $34,545 - $151,998	-98,700 Reduced 39.51%	151,100 $68,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.81 $126,404 - $269,441	-332,644 Reduced 57.11%	249,800 $131,000
Q2 2022 Aug 12, 2022	BUY	$0.5 - $2.66 $215,288 - $1.15 Million	430,576 Added 283.52%	582,444 $294,000
Q1 2022 May 13, 2022	SELL	$1.87 - $4.77 $180,140 - $459,503	-96,332 Reduced 38.81%	151,868 $349,000
Q4 2021 Feb 11, 2022	BUY	$3.5 - $8.42 $517,650 - $1.25 Million	147,900 Added 147.46%	248,200 $1.18 Million
Q3 2021 Nov 12, 2021	BUY	$6.03 - $7.95 $298,563 - $393,628	49,513 Added 97.49%	100,300 $797,000
Q2 2021 Aug 13, 2021	BUY	$6.32 - $8.38 $254,613 - $337,605	40,287 Added 383.69%	50,787 $353,000
Q1 2021 May 13, 2021	SELL	$6.76 - $8.57 $261,666 - $331,727	-38,708 Reduced 78.66%	10,500 $83,000
Q4 2020 Feb 10, 2021	SELL	$7.02 - $9.83 $2.09 Million - $2.93 Million	-298,031 Reduced 85.83%	49,208 $387,000
Q3 2020 Nov 13, 2020	SELL	$6.51 - $9.33 $1.35 Million - $1.93 Million	-206,800 Reduced 37.33%	347,239 $2.46 Million
Q2 2020 Aug 13, 2020	SELL	$4.01 - $11.04 $182,856 - $503,423	-45,600 Reduced 7.6%	554,039 $5.13 Million
Q1 2020 May 14, 2020	BUY	$3.51 - $8.48 $83,323 - $201,306	23,739 Added 4.12%	599,639 $2.79 Million
Q4 2019 Feb 13, 2020	BUY	$7.23 - $8.55 $109,896 - $129,960	15,200 Added 2.71%	575,900 $4.4 Million
Q3 2019 Nov 13, 2019	BUY	$6.42 - $9.0 $100,794 - $141,300	15,700 Added 2.88%	560,700 $4.31 Million
Q2 2019 Aug 12, 2019	BUY	$6.1 - $8.78 $556,320 - $800,735	91,200 Added 20.1%	545,000 $3.73 Million
Q1 2019 May 14, 2019	SELL	$7.6 - $9.4 $20,520 - $25,380	-2,700 Reduced 0.59%	453,800 $3.65 Million
Q4 2018 Feb 13, 2019	BUY	$6.51 - $10.19 $2.97 Million - $4.65 Million	456,500 New	456,500 $3.42 Million

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account